Wishing you all the joys of the season! 
South & Central America ELISA Diagnostics Tests Market Forecast to 2030
South & Central America ELISA Diagnostics Tests Market Forecast to 2030 – Regional Analysis – by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Innovative Product Launches Bolster South & Central America ELISA Diagnostics Tests Market
ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities. Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. “Human Factor IX Kit” is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests. Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans. In December 2022, Pictor Limited announced a new product launch of the “PictArray SARS-CoV-2 Antibody Test,” which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.
South & Central America ELISA Diagnostics Tests Market Overview
In Brazil, amid the COVID-19 pandemic, several top manufacturers launched innovative ELISA-based products to diagnose COVID-19 with lower chances by avoiding false negative results. CT Vacinas, a center formed by researchers at the Federal University of Minas Gerais (UFMG) and the Oswaldo Cruz Foundation (Fiocruz), is one such example. Also, the ELISA-based COVID-19 diagnostic kit provided by CT Vacinas is comparably a cheaper product than other kits such as RT-PCR in Sau Paulo.
Further, the American Association for the Advancement of Science (AAAS) 2023 report revealed that Brazilian startup “Biolinker” in Sau Paulo developed a low-cost, high-performance COVID-19 diagnostic test kit. Amid the pandemic, within a few months, the company planned to complete the development of a standardized kit for the detection of IgG circulating antibodies in blood serum produced for SARS-CoV-2 variants. The method used for manufacturing the standardized kit was ELISA. The kit produced by ELISA platform was affordable and quick test that can be used anywhere for epidemiological screening purposes for COVID-19 patients. Therefore, aforementioned factors are responsible for the ELISA diagnostic test market growth in Brazil.
South & Central America ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)
South & Central America ELISA Diagnostics Tests Market Segmentation
The South & Central America ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the South & Central America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.
In terms of test type, the South & Central America ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.
Based on application, the South & Central America ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.
By end user, the South & Central America ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.
Based on country, the South & Central America ELISA diagnostics tests market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America ELISA diagnostics tests market share in 2022.
Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., DiaSorin SpA, and Elabscience Biotechnology Inc. are some of the leading companies operating in the South & Central America ELISA diagnostics tests market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America ELISA diagnostics tests market was valued at US$ 87.77 million in 2022 and is expected to reach US$ 129.69 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. Advancements in ELISA-Based procedures and rising incidence of human infections are among the critical factors attributed to the South & Central America ELISA diagnostics tests market expansion.
The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The “AMP’D ELISA Signal Amplification system” is manufactured by Enzo Life Sciences, Inc. The AMP’D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.
Cell Signaling Technology, Inc.’s “PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit,” designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarian for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030. ELISA diagnostic test.
On the contrary, incidents of product recalls hamper the growth of South & Central America ELISA diagnostics tests market.
Based on adoption, the South & Central America ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held 65.9% market share in 2022, amassing US$ 57.86 million. It is projected to garner US$ 88.57 million by 2030 to expand at 5.5% CAGR during 2022-2030.
In terms of test type, the South & Central America ELISA diagnostics tests market is categorized into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held 35.4% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 31.06 million. It is projected to garner US$ 50.18 million by 2030 to expand at 6.2% CAGR during 2022-2030.
Based on application, the South & Central America ELISA diagnostics tests market is categorized into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held 41.2% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 36.20 million. It is projected to garner US$ 57.87 million by 2030 to expand at 6.0% CAGR during 2022-2030.
By end user, the South & Central America ELISA diagnostics tests market is categorized into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held 40.3% share of South & Central America ELISA diagnostics tests market in 2022, amassing US$ 35.41 million. It is projected to garner US$ 56.05 million by 2030 to expand at 5.9% CAGR during 2022-2030.
Based on country, the South & Central America ELISA diagnostics tests market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 42.3% share of South & Central America ELISA diagnostics tests market in 2022. It was assessed at US$ 37.13 million in 2022 and is likely to hit US$ 56.91 million by 2030, exhibiting a CAGR of 5.5% during 2022-2030.
Key players operating in the South & Central America ELISA diagnostics tests market are Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., DiaSorin SpA, and Elabscience Biotechnology Inc., among others.
In June 2021, Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products.
In June 2023, IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry’s Most Comprehensive Renal Testing Portfolio.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America ELISA diagnostics tests market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America ELISA diagnostics tests market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
1.2.1 South & Central America ELISA Diagnostic Tests Market – by Adoption
1.2.2 South & Central America ELISA Diagnostic Tests Market – by Test Type
1.2.3 South & Central America ELISA Diagnostic Tests Market – by Application
1.2.4 South & Central America ELISA Diagnostic Tests Market – by End User
1.2.5 South & Central America ELISA Diagnostic Tests Market – by Country
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America ELISA Diagnostic Test Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Infectious Diseases Among Animals
4.1.2 Increasing Incidence of Human Infections
4.2 Key Market Restraints
4.2.1 Incidents of Product Recalls
4.3 Key Market Opportunities
4.3.1 Innovative Product Launches
4.4 Future Trends
4.4.1 Advancements in ELISA-Based Procedures
5. ELISA Diagnostic Tests Market – South & Central America Market Analysis
5.1 Overview
5.2 South & Central America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 – 2030
6. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Adoption
6.1 Overview
6.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
6.3 Human
6.3.1 Overview
6.3.2 Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Veterinary
6.4.1 Overview
6.4.2 Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 South & Central America ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Sandwich ELISA
7.3.1 Overview
7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Indirect ELISA
7.4.1 Overview
7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Competitive ELISA
7.5.1 Overview
7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Multiple & Portable ELISA
7.6.1 Overview
7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 South & Central America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Autoimmune Diseases
8.3.1 Overview
8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Infectious Disease
8.4.1 Overview
8.4.2 Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Cancer Diagnosis
8.5.1 Overview
8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Protein Quantification
8.6.1 Overview
8.6.2 Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 South & Central America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals & Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical & Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Veterinary Hospitals & Diagnostic Laboratories
9.5.1 Overview
9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 – Country Analysis
10.1 South & Central America: ELISA Diagnostic Tests Market
10.1.1 South & Central America: ELISA Diagnostic Tests Market, by Country
10.1.1.1 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
10.1.1.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
10.1.1.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
11. ELISA Diagnostics Test Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in ELISA diagnostics test Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Idexx Laboratories Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Danaher Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DiaSorin SpA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Elabscience Biotechnology Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 SWOT Analysis
12.8.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. ELISA Diagnostic Test Market Segmentation
Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
Table 3. Brazil ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 11. Rest of South & Central America ELISA Diagnostic Tests Market, by Adoption – Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of South & Central America ELISA Diagnostic Tests Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America ELISA Diagnostic Tests Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America ELISA Diagnostic Tests Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. Recent Organic Growth Strategies in ELISA diagnostics Test Market
Table 16. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
Table 17. Glossary of Terms, ELISA Diagnostic Tests Market
LIST OF FIGURES
Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 – 2030
Figure 5. ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
Figure 6. Human: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Veterinary: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. South & Central America ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Infectious Disease: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Protein Quantification: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America: ELISA Diagnostic Tests Market, By Key Country – Revenue (2022) (US$ Million)
Figure 25. South & Central America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
Figure 26. Brazil: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Argentina: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of South & Central America: ELISA Diagnostic Tests Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in ELISA Diagnostics Test Market
The List of Companies – South & Central America ELISA Diagnostics Tests Market
1. Bio-Rad Laboratories Inc.
2. Idexx Laboratories Inc.
3. F. Hoffmann-La Roche Ltd.
4. Thermo Fisher Scientific Inc.
5. Abbott Laboratories
6. Danaher Corp.
7. DiaSorin SpA
8. Elabscience Biotechnology Inc.
You must be logged in to post a review.
Reviews
There are no reviews yet.